- Release Date: 05/02/26 08:21
- Summary: Nyrada Phase IIa Clinical Trial Factsheet
- Price Sensitive: No
- Download Document 262.86KB
- Forums
- ASX - By Stock
- NYR
- Ann: Nyrada Phase IIa Clinical Trial Factsheet
NYR
nyrada inc.
Add to My Watchlist
2.07%
!
59.3¢
Ann: Nyrada Phase IIa Clinical Trial Factsheet
-
Top Stories
- There are more pages in this discussion • 56 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
Last
59.3¢ |
Change
-0.013(2.07%) |
Mkt cap ! $153.0M | |||
| Open | High | Low | Volume |
| 61.5¢ | 62.5¢ | 59.0¢ | 208.5K |
Buyers (Bids)
| Vol. | Price($) |
|---|---|
| 424 | 59.0¢ |
Sellers (Offers)
| Price($) | Vol. |
|---|---|
| 61.5¢ | 10000 |
| Last trade - 16.15pm 16/04/2026 (20 minute delay) ? |
Featured News
| NYR (ASX) Chart |
The Watchlist
OR3
ORE RESOURCES LIMITED
Nicholas Rathjen, Managing Director
Nicholas Rathjen
Managing Director
SPONSORED BY The Market Online